Menu

Language Gene Dethroned

Contrary to earlier results, FOXP2 did not undergo a “selective sweep” as humans developed language, a study finds.

Aug 3, 2018
Shawna Williams

ABOVE: ISTOCK, SUSANNEB

The gene FOXP2, known to be important to language ability, has not undergone strong selection in humans over the past few hundred thousand years, a new genomic analysis finds. The results, published yesterday (August 2) in Cell, overturn those of a 2002 study that found evidence of a rapid and recent spread of a FOXP2 variant through human populations.

Defects in FOXP2 were discovered in a family with multiple members who had speech impairments, and the gene became known for its importance in language ability. By appearing to show that speech-friendly variants of the gene had swept through the human population relatively recently, the 2002 study fed a popular idea that the gene was key to the evolution of language and for setting Homo sapiens apart from other animals. Subsequent studies have found “human” FOXP2 variants in Neanderthals and Denisovans, however.

With the release of the new results, “It’s good that it is now clear there is actually no sweep signal at FOXP2,” Wolfgang Enard of Ludwig Maximilian University of Munich in Germany, a coauthor of the 2002 study, tells Nature.

Enard and his coauthors based their original study on just 20 people, Nature notes, a small number of whom had African ancestry. The new analysis used much larger, more diverse datasets, and found no evidence of recent selection pressure on FOXP2. (The results were inconclusive for signs of selection prior to 200,000 years ago.) The authors of the new paper suggest that the 2002 study’s contradictory results may be explained by its sample’s small size and lack of diversity.

Read “The Flap Over FoxP2

“If you’re asking a question about the evolution of humans as a species,” Elizabeth Atkinson, a population geneticist at the Broad Institute of Harvard and MIT and a coauthor of the new paper, tells Nature, “you really do need to include a diverse set of people.” 

Read “Why Human Speech is Special

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.